Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept

JIM O'MARA NAMED CHIEF EXECUTIVE OFFICER BOSTON, Jan. 4, 2018 -- (Healthcare Sales & Marketing Network) -- Neurogastrx, Inc., a private biopharmaceutical company focused on discovering and developing therapies for gastrointestinal disorders affecting t... Biopharmaceuticals, Venture Capital, Personnel Neurogastrx, Gastroparesis

http://salesandmarketingnetwork.com/news_release_bs.html?ID=2043358

Source: HSMN NewsFeed - January 4, 2018 Category: Pharmaceuticals Source Type: news